Sign in →

Test Code LAB2360 Mixing Studies

Important Note

Patients must not be taking Heparin or Coumadin.  These can erroneously effect results.

Blue tubes that are not filled to the required line will not be processed, due to result integrity being affected.  

Useful For

Detecting the presence of coagulation factor deficiencies and the presence of nonspecific inhibitors.  Deficiency or inhibition of coagulation factors can prolong PT and/or PTT results.

Methodology

Clot Detection

Profile Information

Test Code Test Name

Available

Separately

Always

Performed

LAB320 Protime/INR Yes Yes
LAB325 Activated Partial Thromboplastin Time (APTT) Yes Yes

Testing Algorithm:

If the PT is prolonged >3SD of the normal range, a Protime Mixing Study will be performed at an additional charge.

If the APTT is prolonged >3SD of the normal range, an APTT Mixing study will be performed at an additional charge.  A thrombin time will be performed to rule out the presence of heparin.

 

Reflex Tests

Test Code Test Name Test Components
LAB2360 Protime Mixing Study PT Patient Plasma/Normal Plasma 1:1 Mix
PT Patient Plasma/Factor Diluent 1:1 Mix
Interpretation
APTT Mixing Study PTT Patient Plasma/Normal Plasma Mix 1:1 Mix
PTT Patient Plasma/Factor Diluent Mix 1:1
Thrombin Time
Interpretation

 

Performing Laboratory

Bozeman Health Laboratory Services

Specimen Requirements

Specimen must arrive and be tested within 4 hours of draw.

 

Specimen Type: Whole blood
Container/Tube: Blue top (3.2% sodium citrate)

Specimen Volume: 2 full tubes

Specimen Minimum Volume: 1 full tube

Collection Instructions:

1. Immediately after draw, invert tubes several times to mix blood with additive.

2. Send specimen in original tube.

3. If there is a delay in transport of >4 hours, specimen must be double-centrifuged to prepare a platelet-free plasma specimen as follows:

a. Immediately centrifuge at 3,200 rpm for 15 minutes.

b. Carefully remove plasma from cells avoiding platelet/buffy coat, and transfer plasma into a plastic tube.

c. Centrifuge plastic tube at 3,200 rpm for 15 minutes.

d. Carefully remove top portion of plasma and transfer plasma into a plastic tube leaving approximately 250 mcL in bottom to discard.

e. Double-centrifuged plasma should be aliquoted (0.5 mL-1 mL each) into clearly labeled plastic tubes. (Glass vial is not acceptable)

f. Plasma specimens should be frozen at <-40° C, if possible, and sent together in same container with at least 5 lbs of dry ice. Specimens must arrive in a frozen state.

4.  If the patient has a hematocrit of >55 (within the last 14 days):

a.   A new 'Adjust Tube' will automatically be ordered.

b.  Phlebotomist or RN should contact the lab to obtain a tube with the correct anticoagulant ratio.

c.  The lab will mark the tube appropriately as 'adjusted'.

d.  Tube will be sent by the lab to the phlebotomist or RN to draw the patient.

e.  Process the 'adjusted' tube as stated above in steps 1-3.

Additional Information: Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results.

Specimen Transport Temperature

Ambient (whole blood) <4 hours/Frozen (plasma) >4 hours

Specimen Stability

Specimen Type Temperature Time
Whole Blood (unspun) Ambient 4 hours
Plasma Na Citrate Ambient 4 hours
Plasma Na Citrate (double spun) Frozen 14 days

 

Reference Values

Component Normal Range

Mixing Study

Reflex Value

Critical Values
PT 12.0-14.5 seconds ≥ 15.6  
INR 0.9-1.1   >5.0
PTT 24-35 seconds ≥ 38.2 >100 seconds
Thrombin Time 15.0-18.0 seconds    

If the result obtained with the immediate normal plasma mixture shows only partial or no correction, and the result obtained with the diluent mixture shows near correction to the reference range or only mild prolongation, then a non-specific inhibitor such as lupus anticoagulant (LA) is suspected. Plasma suspected of containing LA should be further tested with LA specific tests to confirm the presence of lupus anticoagulant.

Some inhibitors will demonstrate a delayed type inhibitor pattern, with time and/or temperature dependence. In cases with a delayed type inhibitor, the APTT immediate mix will correct to within the reference range, however, the APTT incubated mix will be prolonged. Although rare, the presence of a factor inhibitor, such as a factor VIII inhibitor, will increase the risk of life-threatening bleeding. The presence of a factor inhibitor can be confirmed by a Bethesda assay for that factor.

Day(s) Test Set Up

Monday through Sunday

Test Classification and CPT Coding

85610 PT

85611 PT plasma fraction (if needed)

85730 PTT

85732 PTT plasma fraction (if needed)

85670 Thrombin Time (if needed)

80500-Pathology Interp (if needed)